
Why India fails to improve its air quality standards
Despite a growing number of initiatives generating momentum for improving air quality, meeting the World Health Organization (WHO)'s air quality guidelines remains a steep climb for India.India launched its Air Quality Index (AQI) on September 17, 2014, offering a simple numerical scale to communicate air quality and its health impacts. While the initiative marked a significant step forward, debates continue over the AQI's formulation, highlighting a need for stronger scientific leadership. Around the same period, China was battling a similar air quality crisis. While China moved decisively, India faltered — not due to a lack of scientific understanding, but rather because of insufficient political will. The launch of the National Clean Air Programme (NCAP) in 2019 was a moment of renewed hope. It aimed to cut particulate pollution by 20-30 per cent by 2024 (from 2017 levels), later revised to a more ambitious 40 per cent reduction by 2026. Think-tanks, academic institutions, and civil society rallied behind the mission, and statutory bodies like the Commission for Air Quality Management (CAQM) were created to drive co-ordinated action in the National Capital Region.Despite this institutional push, however, significant and consistent improvements in air quality remain elusive nationwide.Comprehensive studies are crucial for evaluating policy scenarios and understanding how various interventions impact pollution dynamics. In this context, advanced air quality modelling has emerged as a powerful decision-support tool.Modelling studiesHigh-performance air quality models help answer fundamental questions about the sources of pollution in a city, pollution from primary emissions versus secondary chemical formation, and local pollution versus that transported from outside.Such models enable policymakers to evaluate whether specific interventions — like the shift from BS-IV to BS-VI fuel standards or large-scale initiatives such as the Pradhan Mantri Ujjwala Yojana (PMUY) (which received an initial investment of ₹800 billion ($9,300 million)) — are likely to produce measurable improvements in air quality, and where those benefits are most likely to be seen.A study published in a leading international journal underscores the gravity of the air pollution crisis in the Indo-Gangetic Plain — one of the world's most densely populated and polluted regions. Annual average PM2.5 concentrations consistently exceed 80 μg/m³, with winter peaks surging to between 150 and 230 μg/m³ — far above safe limits. According to the WHO guidelines, the annual average for PM2.5 should not exceed 5 µg/m³, and 24-hour concentrations should remain below 15 µg/m³ on all but 3-4 days in a year. For PM10, the corresponding limits are 15 µg/m³ annually and 45 µg/m³ in a day. Tackling air pollution in the Indo-Gangetic Plain demands integrated, regional strategies based on the idea of 'airsheds' — analogous to watersheds — that extend well beyond local emissions control.These elevated levels are not driven by local emissions alone. Two major factors contribute to the severity of winter pollution: First, the region experiences a nearly fivefold drop in its ventilation coefficient — a measure of how well the air in a region can 'clean itself' by moving and spreading out pollution. In winter, still air, especially in mountain-ringed areas like the Himalayas — traps pollutants near the ground, worsening air quality.Second, a significant share of secondary PM2.5 forms from precursor gases transported from neighbouring areas. Natural phenomena like temperature inversions, low wind speeds, and the topographical trapping of pollutants often intensify winter pollution levels. Tackling this complex issue demands more than blanket solutions; it requires a nuanced understanding of where air pollution originates, and how it evolves. It is made all the more difficult by geographical diversity, economic pressures, and cross-border pollution.Scientific assessments suggest that primary emissions account for roughly 38 per cent of PM2.5, while secondary formation, driven by chemical reactions in the atmosphere, contributes about 62 per cent. Biomass burning in the domestic sector is the dominant source of primary particulates, whereas secondary pollutants are largely influenced by industrial processes, power generation, and cross-border transport. Another series of studies conducted for various state governments suggests that without bold, transformative action, India is unlikely to ever meet the air quality guidelines of the WHO. Studies comparing business-as-usual and 'most ambitious' intervention scenarios in cities show that even aggressive policies fall short of the WHO benchmarks. These findings emphasise the magnitude of change required — not incremental tweaks, but systemic shifts in energy use, transport, industry, and waste management.Systemic shifts and solutionsAs scientific and policy discussions around air pollution solutions continue, meaningful implementation ultimately hinges on political will. While evaluating political priorities falls outside the scope of this article, one recent scientific insight offers a practical adjustment that could greatly enhance existing policy. The study proposes a shift in how India approaches air quality management: by dividing the country into nine to 11 regional airsheds, each defined by its unique meteorological and topographical characteristics. Under the current framework of the National Clean Air Programme (NCAP), 130 non-attainment cities are individually responsible for meeting pollution reduction targets. However, air pollution doesn't respect municipal or state boundaries — it moves with the wind. This phenomenon, known as transboundary pollution, often renders city-specific plans ineffective. The airshed-based approach groups cities that share similar wind and pollution patterns, enabling more co-ordinated and scientifically grounded interventions. For example, the study shows that Delhi's airshed boundaries shift seasonally. In summer, easterly winds carry pollution from Uttar Pradesh into the capital, while in winter, westerly winds bring pollutants from Haryana. Delhi's clean air efforts could be bolstered by co-ordinated action with neighbouring cities like Noida, Ghaziabad, and Meerut. This pattern repeats across India. In Chennai, winter winds transport pollution from inland Tamil Nadu to the coastal city. Mumbai experiences landward pollution flow from industrial zones seasonally. Even relatively cleaner cities like Bengaluru are impacted by emissions drifting in from nearby regions.Overcoming implementation hurdlesThe message is clear: managing air quality by airshed, not by administrative boundaries, is essential for any realistic and science-driven path toward cleaner air in India.While scientific understanding of India's air pollution crisis has grown substantially in recent years, converting this knowledge into actionable policy continues to be a major hurdle. Implementing an effective airshed-based strategy would require a significant shift in the country's current approach. It would involve restructuring the NCAP to prioritise airshed-level planning, moving beyond city-specific targets; establishing robust interstate co-ordination, especially for cross-jurisdictional airsheds; expanding regulatory efforts to include precursor gases, which play a critical role in the formation of secondary PM2.5, and; developing integrated air quality monitoring systems capable of tracking both primary emissions and the complex chemistry behind secondary pollutant formation.Whether India can achieve the air quality levels recommended by the WHO is not only a scientific question — it is equally a matter of governance and policy commitment. Shivang Agarwal is Technical Fellow, Institute for Governance & Sustainable Development (IGSD), Washington DC. Suresh Ramasubramanya Iyer is Senior Fellow and Area Convenor, Centre for Air Quality Research, The Energy and Resources Institute (TERI), New Delhi.(This article was first published under Creative Commons by 360info.).(Disclaimer: The views expressed above are the author's own. They do not necessarily reflect the views of DH.)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
5 minutes ago
- Business Standard
NB.1.8.1 Covid-19 variant makes up 10% cases globally: Should you worry?
Just when many believed Covid-19 was in the rear-view mirror, a new variant has quietly gained ground. NB.1.8.1, first detected in China in January 2025, now accounts for one in ten Covid-19 cases globally—up from just one in forty a month ago. It has spread across twenty-two countries so far. What is NB.1.8.1 variant? According to the World Health Organization, NB.1.8.1 is among several fast-evolving Omicron-lineage variants. From January to May 2025, global dominance shifted from XEC to LP.8.1, with NB.1.8.1 now surging rapidly. The WHO has classified NB.1.8.1 as a Variant Under Monitoring due to its rise in prevalence and potential public health implications. Officials stress that while vigilance is crucial, there is no cause for alarm. Vaccination remains the best protection against severe illness and death. How NB.1.8.1 behaves and how severe it really is NB.1.8.1 is a sublineage of the Omicron JN.1 family. It carries similar characteristics—high transmissibility, but mostly mild to moderate illness. It also includes new mutations on the spike protein, which may enhance its ability to spread and evade immunity. So far, there is no evidence to suggest NB.1.8.1 causes more severe disease, hospitalisations or death compared to previous variants. NB.1.8.1 symptoms: What to watch for Common symptoms include: Dry, persistent cough Runny or blocked nose Fatigue and general body aches Sore throat Fever or chills Headache or hoarseness in some cases Many report being able to go about daily activities but feel unusually tired and sluggish. Are vaccines still effective against NB.1.8.1? Updated vaccines, including the latest Omicron-targeted boosters, are designed to protect against the JN.1 family. While they may not prevent all infections, they continue to reduce the risk of hospitalisation and severe outcomes. Expert guidance includes: If you are over sixty, have chronic health conditions or are immunocompromised, get a booster if it has been more than six months since your last dose If you are healthy and under sixty, no new dose is required at present Use masks in public transport and crowded indoor spaces How to manage NB.1.8.1 symptoms at home In most cases, NB.1.8.1 does not require hospitalisation. Here is what helps: Rest and stay well hydrated Use paracetamol or other over-the-counter medications for fever or aches Recovery generally takes five to seven days If you are elderly or immunocompromised, speak to your doctor early. Antiviral medication is most effective within five days of the onset of symptoms. Warning signs: When to seek emergency help Seek urgent medical care if you experience any of the following: Difficulty breathing Chest pain or tightness Confusion or trouble staying awake Severe dizziness or fainting Do not panic, but stay informed Experts believe NB.1.8.1 will follow a familiar seasonal pattern seen with earlier variants—periodic surges during winter and summer months. Most infections remain mild. Vaccines continue to work. Keep an eye on symptoms, isolate if unwell, and consult your doctor when in doubt.


Hans India
an hour ago
- Hans India
Consumer Choice Center Advocates for Significant Revisions to WHO Governance and Operations Amidst Approval of Increased Mandatory Membership
India: The World Health Organization (WHO) is facing intense scrutiny following the approval of a 20% increase in mandatory membership dues, amounting to an additional $120 million per year extracted directly from taxpayers Consumer Choice Center joins critics in questioning whether the organization truly deserves this financial boost, citing significant issues with transparency, accountability, and the allocation of funds. In a country like India, where over 60% of health expenditure is out-of-pocket and public health systems remain severely underfunded, questions around the WHO's spending priorities resonate deeply. The World Health Organization (WHO) recently announced an increase in its mandatory membership dues-known as assessed contributions—by 20%. For 2026 and 2027, this will amount to an additional $120 million per year , drawn straight from taxpayers around the globe. The WHO allocates funding through both voluntary contributions, which are earmarked for specific health programs, and assessed contributions. Assessed contributions provide the WHO leadership, including Director-General Tedros Adhanom Ghebreyesus, with greater discretion in how the funds are utilized. These funds are directed into flexible funding streams. This occurs while global healthcare systems experience challenges related to underfunding, growing waitlists, and staff shortages. Funds are being allocated to various initiatives, including upgrades to the WHO's Geneva headquarters. Senior staff benefits include education allowances of $33,000 per child. The total annual cost for the WHO's 301 most senior staff is approximately $130 million, averaging $432,000 per person, inclusive of benefits and allowances. Sharing his thoughts on the potential utilisation of these additional funds, Fred Roeder, Managing Director, Consumer Choice Center said, 'The $120 million being extracted in new dues each year could directly fund healthcare for 15,000 Germans, 40,000 Poles, 82,000 Georgians, 100,000 South Africans and 500,000 Indians . In India, $120 million annually could fund cancer treatment for 40,000 patients under Ayushman Bharat or cover the full immunization of over 2 million children. That same amount could also strengthen tobacco cessation services across the country, which remain vastly under-resourced despite India having over 260 million tobacco users . Even more troubling, this shift toward 'core funding' is part of a deliberate WHO strategy: to move away from specific, donor-driven initiatives and toward general budget increases it can spend at will—on salaries, travel, and yes, real estate. These are not funds being poured into pandemic preparedness or child vaccination programs. They are being funnelled into a top-heavy administrative structure with minimal transparency and questionable accountability.' The WHO's defenders argue that the organization needs more freedom to respond to global health threats. But freedom without scrutiny leads to mission drift and misallocation. The organization already has a poor record of pandemic response and a reputation for political entanglements. Its handling of tobacco control in India reflects this too—offering ideological prescriptions rather than collaborative, evidence-based support that balances public health, trade, and economic development. The last thing it needs is a blank check. The world needs a lean, targeted health response team. Let's refocus the WHO on solving global health crises, prioritizing impact over institutional expansion. National governments should refuse further increases to assessed contributions until the WHO commits to radical transparency reforms, trims senior compensation packages, and rededicates itself to programmatic funding that puts patient care first. We owe that much to the people who are actually sick—and not just those with corner offices in Geneva. India, as a G20 leader and a major player in global health diplomacy, should demand accountability before committing more taxpayer funds. It must condition future WHO funding on results-driven support for local challenges—like modernizing tobacco regulation, enabling farmer transitions, and enforcing traceability to combat the illicit trade that harms both public health and revenue. Consumer Choice Center The Consumer Choice Center is an independent, non-partisan consumer advocacy group championing the benefits of freedom of choice, innovation, and abundance in everyday life. Through research and educational outreach, we advocate for smart policies that promote growth, lifestyle choice, and tech innovation. We empower consumers to raise their voice and fight for their right to choose—whether it's the products they buy, the technologies they use, or the lifestyle they live.


Time of India
an hour ago
- Time of India
We can forget COVID-19, it's not a cause for concern, say health experts, as they explain the reason behind the surge in India
COVID-19 is becoming milder, but occasional surges are expected. Experts say the virus is endemic and constantly evolving. Rising cases are due to waning immunity and seasonal factors. Vulnerable populations should take precautions. The WHO declared the end of COVID-19 as a public health emergency two years ago. Cases are rising in Southeast Asia, including India. Tired of too many ads? Remove Ads Covid Becoming Milder Every Passing Year: Expert Tired of too many ads? Remove Ads Surge in India part of broader trend Tired of too many ads? Remove Ads 'Ups and downs expected because the virus is endemic' COVID-19 is becoming less severe over time, but occasional increases in cases are expected as the virus becomes endemic and continues to change, scientists say. They reassure the public that there is no major cause for alarm. The experts addressed concerns about the rising number of cases in different parts of India . They believe it is due to weakening immunity combined with seasonal factors, such as extreme temperatures that cause people to stay indoors in air-conditioned environments. They emphasised the need for caution, especially for those who are more vulnerable."With every passing year, COVID-19 is causing milder infections. It is (now) just another respiratory illness and less dangerous than flu. We can forget COVID-19 as a special case. It is not a cause of concern," said Dr. Chandrakant Lahariya, a global health Agarwal from Ashoka University added, "All the subvariants are similar, having a lower virulence but high infectivity. While highly susceptible people can still get severe disease, the vast majority don't, especially those who have had prior infections or vaccines."The World Health Organization (WHO) declared the end of COVID-19 as a public health emergency in May 2023. Health experts now describe the disease as seasonal, endemic, or restricted to certain of June 6, there were over 5,300 active cases in India, with nearly 500 new cases reported in the last 24 hours. More than 4,700 people have recovered. Since January, 55 deaths have been reported, mainly among individuals with pre-existing conditions, according to the Union Health advised that "People with pre-existing illnesses and those older than 65 should follow standard precautions, as they would against any other respiratory infection -- not just for COVID-19."Kerala is the most affected state with over 1,600 cases, followed by Gujarat, West Bengal, Delhi, and Maharashtra, according to ministry increase in cases in India is part of a broader trend in Southeast Asia, including Singapore, Malaysia, Thailand, and Hong surveillance by the Council of Scientific and Industrial Research-National Chemical Laboratory (NCL) has detected the presence of the virus in samples from sewage treatment plants in Pune, according to the Times of sequencing of samples from western and southern India has shown links to Omicron subvariants LF.7, XFG, JN.1, and NB.1.8.1. Rajiv Behl, Director General of the Indian Council of Medical Research (ICMR), said earlier this week that the cases are not severe and there is no need to WHO has classified LF.7 and NB.1.8.1 as 'variants under monitoring' (VUM). JN.1 has been circulating in India since November Satyajit Rath explained that the subvariants are likely better at binding to human cells, despite existing antibodies."However, the important issue here is not their infectivity, but their tendency to cause severe disease, or 'virulence'," Rath experts said that ups and downs in infections are expected because the virus is now endemic and constantly stated, "People need not worry themselves until they are informed of a new 'variant of concern'. VUM is not relevant to the public, but only to public health authorities."Lahariya advised the public to get information from reliable sources and avoid sharing unverified messages. Rath suggested monitoring the virulence of new emphasised that "National and state governments in India should keep a watch on cases, monitor the trends in new cases and share data widely. The linkage between infections and clinical outcomes should be explored to understand the clinical features of the variants in circulation."Rath highlighted the need to address systemic issues in public health systems and healthcare questioned, "Are we making next-generation Covid vaccines at all? Are we making them available widely and affordably? Are we even carefully tracking evidence to see how well or poorly the current vaccine-induced immunity functions against emerging strains?"He added, "And if not, we are throwing poor communities onto their own resources even for taking such simple precautions, and that is a systemic problem."(Inputs from PTI)